Hosted on MSN1mon
TELO Treatment Amazes in Preclinical TrialTelomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback